News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
180,551 Results
Type
Article (7559)
Company Profile (118)
Press Release (172868)
Multimedia
Podcasts (82)
Webinars (11)
Section
Business (54506)
Career Advice (392)
Deals (9875)
Drug Delivery (34)
Drug Development (32184)
Employer Resources (74)
FDA (2811)
Job Trends (4260)
News (97614)
Policy (6898)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Standard (1)
Academia (277)
Accelerated approval (6)
Adcomms (4)
Allergies (47)
Alliances (12470)
ALS (61)
Alzheimer's disease (490)
Antibody-drug conjugate (ADC) (132)
Approvals (2974)
Artificial intelligence (165)
Autoimmune disease (64)
Automation (10)
Bankruptcy (66)
Best Places to Work (3243)
BIOSECURE Act (16)
Biosimilars (105)
Biotechnology (76)
Bladder cancer (39)
Brain cancer (19)
Breast cancer (152)
Cancer (1548)
Cardiovascular disease (102)
Career advice (363)
Career pathing (28)
CAR-T (105)
CDC (13)
Cell therapy (240)
Cervical cancer (7)
Clinical research (28677)
Collaboration (609)
Compensation (643)
Complete response letters (22)
COVID-19 (700)
CRISPR (20)
C-suite (369)
Cystic fibrosis (39)
Data (2286)
Decentralized trials (1)
Denatured (13)
Depression (61)
Diabetes (123)
Diagnostics (650)
Digital health (8)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (62)
Drug pricing (63)
Drug shortages (3)
Duchenne muscular dystrophy (67)
Earnings (24588)
Editorial (40)
Employer branding (10)
Employer resources (63)
Events (36440)
Executive appointments (440)
FDA (3858)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (444)
Gene editing (43)
Generative AI (17)
Gene therapy (156)
GLP-1 (330)
Government (852)
Grass and pollen (1)
Guidances (138)
Healthcare (2373)
HIV (22)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (81)
Immuno-oncology (30)
Indications (40)
Infectious disease (768)
Inflammatory bowel disease (67)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (85)
Interviews (66)
IPO (5855)
IRA (19)
Job creations (1043)
Job search strategy (281)
JPM (35)
Kidney cancer (8)
Labor market (74)
Layoffs (178)
Leadership (28)
Legal (945)
Liver cancer (31)
Longevity (2)
Lung cancer (263)
Lymphoma (125)
Machine learning (16)
Management (23)
Manufacturing (313)
MASH (102)
Medical device (467)
Medtech (469)
Mergers & acquisitions (4509)
Metabolic disorders (449)
Multiple sclerosis (72)
NASH (8)
Neurodegenerative disease (90)
Neuropsychiatric disorders (35)
Neuroscience (945)
NextGen: Class of 2026 (1057)
Non-profit (276)
Now hiring (51)
Obesity (215)
Opinion (188)
Ovarian cancer (49)
Pain (56)
Pancreatic cancer (61)
Parkinson's disease (75)
Partnered (4)
Patents (146)
Patient recruitment (189)
Peanut (18)
People (18133)
Pharmaceutical (36)
Pharmacy benefit managers (7)
Phase 1 (8655)
Phase 2 (13165)
Phase 3 (9665)
Pipeline (2011)
Policy (134)
Postmarket research (516)
Preclinical (3252)
Press Release (19)
Prostate cancer (62)
Psychedelics (20)
Radiopharmaceuticals (126)
Rare diseases (284)
Real estate (1236)
Recruiting (32)
Regulatory (6597)
Reports (28)
Research institute (314)
Resumes & cover letters (44)
RNA editing (4)
RSV (26)
Schizophrenia (103)
Series A (73)
Series B (52)
Service/supplier (4)
Sickle cell disease (23)
Special edition (24)
Spinal muscular atrophy (49)
Sponsored (5)
Startups (990)
State (1)
Stomach cancer (2)
Supply chain (24)
Tariffs (47)
The Weekly (68)
Vaccines (257)
Venture capital (47)
Weight loss (95)
Women's health (19)
Worklife (15)
Date
Today (33)
Last 7 days (184)
Last 30 days (727)
Last 365 days (11090)
2026 (1072)
2025 (11150)
2024 (12584)
2023 (14394)
2022 (16282)
2021 (17914)
2020 (15279)
2019 (10150)
2018 (7276)
2017 (9045)
2016 (7433)
2015 (9432)
2014 (7161)
2013 (5168)
2012 (5014)
2011 (4948)
2010 (4874)
Location
Africa (211)
Alabama (21)
Arizona (28)
Arkansas (2)
Asia (14420)
Australia (1616)
California (4269)
Canada (859)
China (721)
Colorado (160)
Connecticut (176)
Delaware (181)
Europe (26079)
Florida (594)
Georgia (129)
Idaho (4)
Illinois (227)
India (22)
Indiana (140)
Iowa (13)
Japan (170)
Kansas (72)
Kentucky (11)
Louisiana (1)
Maine (2)
Maryland (426)
Massachusetts (3352)
Michigan (49)
Minnesota (128)
Mississippi (2)
Missouri (30)
Montana (1)
Nebraska (6)
Nevada (14)
New Hampshire (7)
New Jersey (1376)
New Mexico (7)
New York (1372)
North Carolina (552)
Northern California (2252)
Ohio (120)
Oklahoma (7)
Oregon (13)
Pennsylvania (743)
Puerto Rico (12)
Rhode Island (11)
South America (252)
South Carolina (6)
Southern California (1632)
Tennessee (16)
Texas (454)
United States (14700)
Utah (91)
Virginia (90)
Washington D.C. (24)
Washington State (271)
West Virginia (1)
Wisconsin (19)
180,551 Results for "dance biopharm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets
October 15, 2025
·
5 min read
Mergers & acquisitions
Merck, AstraZeneca Cancer Collaborator Gets Swallowed Up by Sino Biopharm
Shanghai-based LaNova Medicines—which has captured the attention of some of the biggest Western pharmas—will be folded into fellow Chinese company Sino Biopharmaceutical in a deal worth up to $951 million.
July 16, 2025
·
1 min read
·
Tristan Manalac
Press Releases
QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025
September 18, 2025
·
6 min read
Press Releases
EVA Pharma and Zhejiang Jinhua CONBA Bio-Pharm Sign Strategic Supply Agreement
July 1, 2025
·
3 min read
Press Releases
Kexing Biopharm’s GB18 project received clearance of IND application from NMPA and FDA
May 29, 2025
·
2 min read
Press Releases
Ann Arbor-based Life Science Companies TSRL, AnchorBio, and AAPharmaSyn Launch The A2 BioPharm Collaborative at BIO 2025
June 16, 2025
·
1 min read
Press Releases
Aviva Biopharm Inc. Unveils Groundbreaking Pre-Clinical Data on d3-T, a First-in-Class Testosterone Therapy for Women at ENDO 2025
July 14, 2025
·
3 min read
Press Releases
Xuanzhu Biopharm’s Xuanyuening® (BireociclibTablets) Approved for Dual Indications, Bringing Innovative Breakthroughs to Breast Cancer Treatment
May 16, 2025
·
5 min read
Policy
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
On the evening of May 5, Kexing Biopharm announced it had obtained a “Certificate of GMP Compliance of a Manufacturer” granted by the Norwegian Medical Products Agency in accordance with the European Medicines Agency regulations.
May 10, 2024
·
2 min read
TC BioPharm to Present at the Sequire Investor Summit
TC BioPharm today announced its participation at the upcoming Sequire Investor Summit 2024 scheduled for January 23-25, 2024.
January 18, 2024
·
2 min read
1 of 18,056
Next
